Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 13851-13900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06657833
DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
NARecruiting
128 participants
Started: Dec 17, 2024 · Completed: Oct 30, 2027
1 condition1 sponsor9 locations
NCT06564818
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
PHASE3Recruiting
220 participants
Started: Dec 17, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors44 locations
NCT06803550
Effect of Enhanced Recovery After Surgery for Benign Anorectal Conditions
NARecruiting
100 participants
Started: Dec 17, 2024 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT06101056
Code of Respect (X-CoRe): Trial of a Multi-level Sexual Assault and Sexual Harassment Prevention Intervention for Active Duty Airmen
NARecruiting
1,200 participants
Started: Dec 17, 2024 · Completed: May 31, 2027
2 conditions2 sponsors1 location
NCT06308510
Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer
N/ARecruiting
63 participants
Started: Dec 17, 2024 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT06823700
Safety and Effectiveness Study of SQ-Kyrin System for Functional Mitral Regurgitation in EU
NARecruiting
34 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06959147
High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia
PHASE4Recruiting
46 participants
Started: Dec 17, 2024 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT06601933
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
PHASE2Recruiting
240 participants
Started: Dec 17, 2024 · Completed: Feb 28, 2029
2 conditions2 sponsors4 locations
NCT06614738
Microbial and Environmental Factors Associated with Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)
N/ARecruiting
50 participants
Started: Dec 17, 2024 · Completed: May 17, 2027
1 condition1 sponsor2 locations
NCT06687070
APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST
PHASE1Recruiting
50 participants
Started: Dec 17, 2024 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT06603441
Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea
N/ARecruiting
150 participants
Started: Dec 17, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06612151
A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
PHASE3Recruiting
438 participants
Started: Dec 17, 2024 · Completed: Dec 1, 2030
1 condition1 sponsor1 location
NCT06735976
Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations
NARecruiting
30 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2029
1 condition2 sponsors1 location
NCT06657729
Oral Feeding Skills of Very Premature Infants
N/ARecruiting
40 participants
Started: Dec 17, 2024 · Completed: May 17, 2026
1 condition1 sponsor1 location
NCT06726460
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
N/ARecruiting
200 participants
Started: Dec 17, 2024 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT06725459
NPWT Reduction Mammaplasty
NARecruiting
92 participants
Started: Dec 17, 2024 · Completed: Nov 1, 2025
5 conditions2 sponsors1 location
NCT06773338
The Impact of Playing Tetris on Migrants' Mental Health
NARecruiting
300 participants
Started: Dec 17, 2024 · Completed: Dec 7, 2025
3 conditions2 sponsors2 locations
NCT06831409
Using CTA Measures to Define Cardiac Risk In NFL Alumni
N/ARecruiting
300 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06359041
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
PHASE1/PHASE2Recruiting
12 participants
Started: Dec 17, 2024 · Completed: Sep 30, 2029
1 condition1 sponsor14 locations
NCT06621602
Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease
N/ARecruiting
100 participants
Started: Dec 17, 2024 · Completed: Apr 30, 2026
2 conditions2 sponsors17 locations
NCT06810466
Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia
NARecruiting
99 participants
Started: Dec 17, 2024 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT06771323
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
PHASE2Recruiting
20 participants
Started: Dec 17, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06672445
Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
PHASE1Recruiting
36 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor8 locations
NCT06727604
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
PHASE2Recruiting
240 participants
Started: Dec 17, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor78 locations
NCT07203443
Child Cognitive-Affective Resilience Following 13-11 Event : A Pluridisciplinary Study of Intergenerational Transmission of a Traumatic Event
NARecruiting
960 participants
Started: Dec 17, 2024 · Completed: Jan 15, 2027
1 condition1 sponsor1 location
NCT06771193
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
N/ARecruiting
200 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2025
4 conditions1 sponsor11 locations
NCT06336798
Bioenergetic Effect of Pioglitazone in CLD-PH
PHASE2Recruiting
20 participants
Started: Dec 17, 2024 · Completed: Feb 29, 2028
2 conditions2 sponsors1 location
NCT06742008
Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral Myocarditis
N/ARecruiting
300 participants
Started: Dec 17, 2024 · Completed: Jun 17, 2025
1 condition1 sponsor1 location
NCT06936618
EIT-Guided Ventilator Settings in AHRF
NARecruiting
17 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT05989828
A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
PHASE1Recruiting
20 participants
Started: Dec 17, 2024 · Completed: Dec 17, 2027
1 condition2 sponsors1 location
NCT06581406
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
PHASE2/PHASE3Recruiting
280 participants
Started: Dec 17, 2024 · Completed: Oct 31, 2031
1 condition1 sponsor24 locations
NCT06722365
Characterization of Fetal Lung With Quantitative Ultrasound
N/ARecruiting
12 participants
Started: Dec 17, 2024 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT06740773
Risk Factors for Complications After Cranioplasty
N/ARecruiting
1,000 participants
Started: Dec 17, 2024 · Completed: Dec 31, 2025
3 conditions3 sponsors3 locations
NCT06577493
Effectiveness of Phenazopyridine for Pain Following Urodynamics
PHASE4Recruiting
66 participants
Started: Dec 17, 2024 · Completed: Jul 1, 2025
1 condition1 sponsor1 location
NCT06741995
Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy
N/ARecruiting
1,000 participants
Started: Dec 17, 2024 · Completed: Dec 17, 2027
1 condition1 sponsor1 location
NCT06908070
Chemoradiotherapy With Surgery Followed by Consolidation Durvalumab
PHASE4Recruiting
38 participants
Started: Dec 17, 2024 · Completed: Dec 17, 2028
1 condition1 sponsor1 location
NCT07092618
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
PHASE2/PHASE3Recruiting
150 participants
Started: Dec 17, 2024 · Completed: Aug 31, 2025
4 conditions1 sponsor1 location
NCT06328127
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
NARecruiting
400 participants
Started: Dec 17, 2024 · Completed: May 31, 2030
1 condition4 sponsors3 locations
NCT06549946
Ixovex-1 Single Agent and Combination Therapy
PHASE1/PHASE2Recruiting
18 participants
Started: Dec 17, 2024 · Completed: Jan 30, 2027
2 conditions2 sponsors1 location
NCT07154992
Clinical Trial to Evaluate the Efficacy of Lacticaseibacillus Rhamnosus CRL1505 in the Prevention of Upper Respiratory Tract Infections in Children
NARecruiting
268 participants
Started: Dec 17, 2024 · Completed: Apr 30, 2027
2 conditions2 sponsors1 location
NCT06729957
Addressing Barriers to Care for Substance Use Disorder Trial
NARecruiting
360 participants
Started: Dec 16, 2024 · Completed: Aug 21, 2026
3 conditions3 sponsors1 location
NCT06763328
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
PHASE3Recruiting
200 participants
Started: Dec 16, 2024 · Completed: Jun 16, 2029
4 conditions2 sponsors3 locations
NCT06685601
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder
NARecruiting
60 participants
Started: Dec 16, 2024 · Completed: May 31, 2027
1 condition4 sponsors2 locations
NCT05922553
Using Mukbang to Improve Appetite, Nutritional Status and Quality of Life in Children With Cancer
NARecruiting
124 participants
Started: Dec 16, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06656715
Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
N/ARecruiting
100 participants
Started: Dec 16, 2024 · Completed: Sep 1, 2028
1 condition1 sponsor1 location
NCT06495294
SWiFT Canada (Study of Whole Blood in Frontline Trauma)
NARecruiting
60 participants
Started: Dec 16, 2024 · Completed: Jun 30, 2026
1 condition9 sponsors1 location
NCT06588634
The PERSEVERE Study
NARecruiting
200 participants
Started: Dec 16, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor24 locations
NCT06685835
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)
PHASE2Recruiting
204 participants
Started: Dec 16, 2024 · Completed: Jan 28, 2027
1 condition1 sponsor72 locations
NCT07023419
Psychiatric Disorders in Addiction - Interest of Screening and Influence on Relapse
N/ARecruiting
100 participants
Started: Dec 16, 2024 · Completed: Oct 16, 2026
1 condition1 sponsor1 location
NCT06783270
T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma
PHASE1Recruiting
10 participants
Started: Dec 16, 2024 · Completed: Jan 1, 2028
1 condition1 sponsor1 location